|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Achieve Life Sciences, Inc. S-8 3/28/24 4:323K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: S-8 Registration Statement - Securities for an HTML 247K
Employee Benefit Plan
2: EX-5.1 Opinion of Counsel re: Legality HTML 14K
3: EX-23.2 Consent of Expert or Counsel HTML 6K
4: EX-FILING FEES Filing Fees HTML 51K
| EX-23.2 |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 relating to the 2018 Equity Incentive Plan, 2017 Employee Stock Purchase Plan and 2023 Non-Employee Director Equity Incentive Plan of Achieve Life Sciences, Inc. (the Company) of our report dated March 28, 2024 relating to the consolidated financial statements of the Company, which appears in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
Chartered Professional Accountants
Vancouver, Canada
March 28, 2024
| This ‘S-8’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / Effective on: | 3/28/24 | 10-K, 8-K | ||
| 12/31/23 | 10-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Achieve Life Sciences, Inc. 10-K 12/31/23 86:11M Donnelley … Solutions/FA 6/09/23 Achieve Life Sciences, Inc. 8-K:5,9 6/07/23 12:229K Donnelley … Solutions/FA 4/28/23 Achieve Life Sciences, Inc. DEF 14A 6/07/23 1:1.8M Donnelley … Solutions/FA 3/16/23 Achieve Life Sciences, Inc. 10-K 12/31/22 89:13M ActiveDisclosure/FA 1/05/17 Achieve Life Sciences, Inc. 8-K:1,5,8,9 1/05/17 9:885K Donnelley … Solutions/FA 11/10/08 Achieve Life Sciences, Inc. 10-Q 9/30/08 15:1.3M Dorsey & Whitney LLP/FA |